A retrospective clinical study of the treatment of high-grade anal dysplasia by infrared coagulation in a population of HIV-positive men who have sex with men

2008 ◽  
Vol 19 (2) ◽  
pp. 118-120 ◽  
Author(s):  
R D Cranston ◽  
S L Hirschowitz ◽  
G Cortina ◽  
A A Moe
2016 ◽  
Vol 72 (1) ◽  
pp. 29-35 ◽  
Author(s):  
Nathalie Willems ◽  
Agnès Libois ◽  
Marcel Nkuize ◽  
Francesco Feoli ◽  
Marc Delforge ◽  
...  

2018 ◽  
Vol 5 ◽  
pp. S3
Author(s):  
Isabelle Etienney ◽  
Laurent Siproudhis ◽  
Lionel Piroth ◽  
Isabelle Poizot-Martin ◽  
Sylvie Radenne ◽  
...  

2016 ◽  
Vol 59 (9) ◽  
pp. 836-842 ◽  
Author(s):  
Jill Tinmouth ◽  
Valentina Peeva ◽  
Henok Amare ◽  
Sandra Blitz ◽  
Janet Raboud ◽  
...  

2012 ◽  
Vol 53 (4) ◽  
pp. 325-331 ◽  
Author(s):  
Steffi Silling ◽  
Alexander Kreuter ◽  
Martin Hellmich ◽  
Jochen Swoboda ◽  
Herbert Pfister ◽  
...  

2018 ◽  
Vol 5 ◽  
pp. S9 ◽  
Author(s):  
Elske Marra ◽  
Matthijs L. Siegenbeek van Heukelom ◽  
Annemiek Leeman ◽  
Tim Waterboer ◽  
Chris J.L.M. Meijer ◽  
...  

2017 ◽  
Vol 19 (1) ◽  
pp. 127-132 ◽  
Author(s):  
Matthijs L. Siegenbeek van Heukelom ◽  
Karien C. M. Gosens ◽  
Jan M. Prins ◽  
Henry J. C. de Vries

AIDS ◽  
2018 ◽  
pp. 1 ◽  
Author(s):  
Gary M. Clifford ◽  
Laurent Siproudhis ◽  
Lionel Piroth ◽  
Isabelle Poizot-Martin ◽  
Sylvie Radenne ◽  
...  

2021 ◽  
pp. 095646242110170
Author(s):  
Irene Fuertes ◽  
Ross Cranston ◽  
Elisa de Lazzari ◽  
Leonardo Rodriguez-Carunchio ◽  
José L Blanco

Background: Ablative treatment of anal high-grade squamous intraepithelial lesions (HSIL) reduces the risk of progression to anal squamous cell carcinoma. Objectives: To identify factors that influence the response to treatment of anal HSIL by electrocautery ablation (ECA) in a population of HIV-positive men who have sex with men (MSM). Design: Retrospective study of ECA treatment response in a prospectively followed anal dysplasia cohort. HIV-positive MSM diagnosed with anal HSIL were included. Demographic and HIV data were recorded. Response to treatment was assessed by biopsy after at least 18 months of follow-up. Results: One hundred and twenty-eight HSILs in 91 men were included in this study. The overall response rate at 18 months was 70.3%. The number of electrocautery sessions required (2 ECA sessions vs 1: adjusted odds ratio [aOR] = 0.36 (95%CI 0.13-1.01); >=3 sessions vs 1: aOR = 0.10 (95%CI 0.04-0.29); p < 0.001]) and the history of previous HPV-related anal pathology (previous anal lesions vs no previous lesions AOR = 2.83 (95%CI 1.14-7.02), p = 0.024) were independently associated with response at 18 months. No serious adverse events were reported. Conclusions: Consideration should be given to alternative therapies in patients with unresolved HSIL after 1 ECA treatment.


Sign in / Sign up

Export Citation Format

Share Document